Coriell Institute for Medical Research
Request a Quote
Donate
Login
View Cart
Samples
OR
Website
Sample Catalog
|
Custom Services
|
Core Facilities
|
Genomic Data Search
Navigation Header
Biobank
NIGMS
NINDS
NIA
NHGRI
NEI
Allen Cell Collection
Rett Syndrome iPSC Collection
Autism Research Resource
HD Community Biorepository
CDC Cell and DNA
J. Craig Venter Institute
Orphan Disease Center Collection
All Biobanks
Research
Overview
Meet Our Scientists
Our Faculty
Our Scientific Staff
Camden Cancer Research Center
Epigenetic Therapies SPORE
Core Facilities
Epigenomics
Camden Opioid Research Initiative (CORI)
The Issa & Jelinek Lab
The Jian Huang Lab
The Luke Chen Lab
The Lab
The Team
Publications
The Scheinfeldt Lab
The Shumei Song Lab
The Nora Engel Lab
The Lab
The Team
Publications
Publications
Services
Overview
Biobanking Services
Core Services
Project Management
Research Support Services
Sample Cataloging
Sample Collection Kits
Sample Data Management
Sample Distribution
Sample Management
Sample Procurement
Sample Storage
Bioinformatics and Biostatistics Services
Cellular and Molecular Services
Biomarker Research Solutions
Cell Culture
Nucleic Acid Isolation and Quality Control
Clinical Trial Support
Overview
Sample Collection
Data Management
Sample Processing and QC
Storage and Distribution
Biomarker Services
Data Analaysis
Core Facilties
Overview
Animal and Xenograft
Bioinformatics and Biostatistics
Cell Imaging
CRISPR Gene Engineering
Flow Cytometry and Cell Sorting
Genomics and Epigenomics
iPSC - Induced Pluripotent Stem Cells
Organoids
Coriell Marketplace
Genomic, Epigenomic and Multiomics Services
Stem Cells and iPSC Services
Core Services
Reprogramming
Characterization and Quality Control
Differentiated Cell Lines
iPSC-Derived Organoids
iPSC Expansion
iPSC Gene Editing
Ordering
Stem Cells
Cell Lines
DNA and RNA
Featured Products
FFPE
HMW DNA
Genomic Data Search
Search by Catalog ID
Help
Create Account
Order Online
Ordering FAQ
FAQs/Culture Instructions
Reference Materials
Biobanks
NIGMS Repository
NHGRI Repository
NINDS Repository
NIA Repository
NIST
GeT-RM
Secondary Distribution Policies
MTA Assurance Form
Shipment Policy
Contact Customer Service
About Us
About Coriell
Meet Our Team
Meet Our Board
Education
Science Fair
Summer Experience
Outreach
Research Program Internship
Press Room
Press Releases
Coriell Blog
Annual Report
Careers
Working at Coriell
Giving
Donate
Giving FAQ
Contact Us
Notices
Legal Notice
IBC Minutes
Login
View Cart
search submit
GM28392
LCL
from
B-Lymphocyte
Description:
ATR-X SYNDROME
ATRX CHROMATIN REMODELER; ATRX
Affected:
Yes
Sex:
Male
Age:
4
YR
(At Sampling)
Sample Description
Overview
Characterizations
Phenotypic Data
External Links
Culture Protocols
Overview
Repository
NIGMS Human Genetic Cell Repository
Subcollection
Heritable Diseases
PIGI Consented Sample
Biopsy Source
Peripheral vein
Cell Type
B-Lymphocyte
Tissue Type
Blood
Transformant
Epstein-Barr Virus
Sample Source
LCL from B-Lymphocyte
Race
White
Ethnicity
Hispanic/Latino
Ethnicity
Spanish, Mexican, and European
Country of Origin
USA
Family Member
1
Family History
N
Relation to Proband
proband
Confirmation
Molecular characterization before cell line submission to CCR
Species
Homo
sapiens
Common Name
Human
Remarks
See Phenotypic Data tab; unaffected father is GM28395 (LCL)
Characterizations
Gene
ATRX
Chromosomal Location
Xq21.1
Allelic Variant 1
Arg2085Cys; ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX
Identified Mutation
c.6253 C>T (p.Arg2085Cys)
Phenotypic Data
Demographic Data
Relation to Proband
proband
Age at Sampling
4 YR
Sex
Male
Age at Diagnosis(If not a control)
2 YR
Hispanic or Latino/Not Hispanic or Latino
Hispanic/Latino
Racial Category
White
Country
USA
Data Elements
Clinical Element Type: General NIGMS Catalog Remarks
(Baseline)
Mutation Information
Gene, variant, consequence, and exon number:
WHOLE EXOME SEQUENCING REVEALED A PATHOGENIC VARIANT (C.6253C>T) IN EXON 28 OF THE ATRX GENE (NM_000489.3) RESULTING IN A MISSENSE MUTATION (P.ARG2085CYS)
Zygosity:
Hemizygous
Notes:
HEMIZYGOUS FOR X-LINKED DISORDER
Age of Symptom Onset and Age at Diagnosis
Age of Symptom Onset:
BIRTH
Age at Diagnosis:
2 YEARS
In Utero History Information
Birth History Information
Dysmorphic Features
Additional Information:
EPICANTHAL EYE FOLDS; WIDE NASAL BRIDGE; INVERTED NIPPLES
Neurological Symptoms
Hypotonia
Additional Information:
CEREBRAL VISUAL IMPAIRMENT; POSSIBLE PERIVENTRICULAR LEUKOMALACIA
Optical and Audiological Symptoms
Musculoskeletal Symptoms
Additional Information:
LOW TONE IN MOUTH; SHORT STATURE
Developmental Milestones
Global developmental delay
Gastrointestinal Symptoms
Genitourinary Symptoms
Respiratory and Cardiovascular Symptoms
Cognitive and Behavioral Symptoms
Additional Information
Testing Performed
Treatments and Assistive Devices
Occupational therapy
Physical therapy
Speech therapy
Orthotics
Communication or learning devices
Medications
MIRALAX
Family History
MOTHER IS AN UNAFFECTED CARRIER
Remarks
See Phenotypic Data tab; unaffected father is GM28395 (LCL)
External Links
Gene Cards
ATRX
Gene Ontology
GO:0003678 DNA helicase activity
GO:0003700 transcription factor activity
GO:0005524 ATP binding
GO:0005634 nucleus
GO:0005720 nuclear heterochromatin
GO:0006281 DNA repair
GO:0006306 DNA methylation
GO:0006310 DNA recombination
GO:0006355 regulation of transcription, DNA-dependent
GO:0007001 chromosome organization and biogenesis (sensu Eukarya)
GO:0007605 perception of sound
NCBI Gene
Gene ID:546
NCBI GTR
300032 ATR-X GENE; ATRX
301040 ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX
OMIM
300032 ATR-X GENE; ATRX
301040 ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX
Omim Description
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE
ATR, NONDELETION TYPE; ATR2
ATR-X SYNDROME; ATRX
X-LINKED ALPHA-THALASSEMIA/MENTAL RETARDATION
Culture Protocols
Split Ratio
1:3
Temperature
37 C
Percent CO2
5%
Percent O2
AMBIENT
Medium
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent
Serum
15% fetal bovine serum Not Inactivated
Substrate
None specified
Subcultivation Method
dilution - add fresh medium
Supplement
-
Pricing
International/Commercial/For-profit:
$373.00
USD
U.S. Academic/Non-profit/Government:
$216.00
USD
Add to Cart
How to Order
Ordering Instructions
MTA / Assurance Form
Statement of Research Intent Form
Related Products
Same Family
NIGMS00001
Miscellaneous
DNA on Demand
Custom Services